Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data

Hauer L, Sellner J

Drug Design, Development and Therapy 2022, 16:3915-3927

Published Date: 10 November 2022